跳至主要内容
临床试验/NL-OMON22647
NL-OMON22647招募中不适用

Targeted therapy selection based on tumor tissue kinase activity profiles for patients with advanced solid malignancies, an exploratory study.

Prof. dr. H.M.W. Verheul, M.D., Ph.D.Head Department of Medical OncologyVU University Medical CenterDe Boelelaan 11171081 HV AmsterdamThe NetherlandsTel: +31 (0)20-4444321/300Fax: + 31 (0)20-4444079Email: h.verheul@vumc.nl0 个研究点目标入组 43 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
43

研究概览

简要总结

/A

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patients presenting with an advanced (unresectable and/or metastatic) solid malignancy for whom no standard treatment is available;
  • 2. Patients should have received at least one prior standard medical treatment regimen for their advanced disease;

排除标准

  • 1. History of cardiac disease:
  • A. Congestive heart failure >NYHA class 2;

研究者

发起方
Prof. dr. H.M.W. Verheul, M.D., Ph.D.Head Department of Medical OncologyVU University Medical CenterDe Boelelaan 11171081 HV AmsterdamThe NetherlandsTel: +31 (0)20-4444321/300Fax: + 31 (0)20-4444079Email: h.verheul@vumc.nl

相似试验

Kinaseprofiling voor therapieselectie bij... | 临床试验